142 related articles for article (PubMed ID: 1871715)
1. A photometric assay for blood coagulation factor XIII.
Fickenscher K; Aab A; Stüber W
Thromb Haemost; 1991 May; 65(5):535-40. PubMed ID: 1871715
[TBL] [Abstract][Full Text] [Related]
2. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma.
Kárpáti L; Penke B; Katona E; Balogh I; Vámosi G; Muszbek L
Clin Chem; 2000 Dec; 46(12):1946-55. PubMed ID: 11106327
[TBL] [Abstract][Full Text] [Related]
3. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
Hellstern P; Schilz K; von Blohn G; Wenzel E
Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
[TBL] [Abstract][Full Text] [Related]
4. A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma.
Oertel K; Hunfeld A; Specker E; Reiff C; Seitz R; Pasternack R; Dodt J
Anal Biochem; 2007 Aug; 367(2):152-8. PubMed ID: 17582378
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a modified colorimetric solid-phase microassay for measuring the activity of cellular and plasma (Factor XIII) transglutaminases.
Thomas V; El Alaoui S; Massignon D; Clément S; Simonet F; Quash G
Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):171-9. PubMed ID: 16313237
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
[TBL] [Abstract][Full Text] [Related]
7. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
Achyuthan KE; Santiago MA; Greenberg CS
Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
[TBL] [Abstract][Full Text] [Related]
8. Determination of factor XIII activity by a new photometric assay in plasma and platelets of healthy blood donors.
Wagner B; Seyfert UT; Gosse M; Wenzel E; Fickenscher K; Ruhl HG
Thromb Res; 1994 Apr; 74(2):169-74. PubMed ID: 8029818
[TBL] [Abstract][Full Text] [Related]
9. Optimisation of a new continuous UV assay for the determination of blood coagulation factor XIII activity in human plasma.
Heins M; Fahron U; Withold W; Rick W
Eur J Clin Chem Clin Biochem; 1994 Jun; 32(6):479-83. PubMed ID: 7918847
[TBL] [Abstract][Full Text] [Related]
10. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
Mimuro J; Kimura S; Aoki N
J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
[TBL] [Abstract][Full Text] [Related]
11. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
Ragaz S; Kemp G; Furlan M; Beck EA
Thromb Haemost; 1976 Dec; 36(3):537-41. PubMed ID: 1037151
[TBL] [Abstract][Full Text] [Related]
12. Measurement of factor XIII activity in plasma.
Katona É; Pénzes K; Molnár É; Muszbek L
Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
[TBL] [Abstract][Full Text] [Related]
13. Microtiter assay for measurement of factor XIII activity in plasma.
Dempfle CE; Harenberg J; Hochreuter K; Heene DL
J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910
[TBL] [Abstract][Full Text] [Related]
14. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
15. Quantification of coagulation factor XIII activity by a thio-NADH based assay using factor XIII immuno-depleted plasma as a diluent for calibration.
Kappel A; Stephan S; Christ G; Pechmann L; Duwe C; Fischer B; Hahn M; Althaus H; Ehm M; Schwarz H; Vitzthum F
Clin Chem Lab Med; 2010 Dec; 48(12):1739-43. PubMed ID: 20828366
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
[TBL] [Abstract][Full Text] [Related]
17. A novel assay for factor XIII based on cross-linking of synthetic peptides: analysis of different substrates.
Kusch M; Grundmann C; Keitel S; Seitz R; König H
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):575-80. PubMed ID: 16988554
[TBL] [Abstract][Full Text] [Related]
18. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2).
Katona E; Haramura G; Kárpáti L; Fachet J; Muszbek L
Thromb Haemost; 2000 Feb; 83(2):268-73. PubMed ID: 10739385
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
[TBL] [Abstract][Full Text] [Related]
20. Kinetic determination of blood coagulation Factor XIII in plasma.
Muszbek L; Polgár J; Fésüs L
Clin Chem; 1985 Jan; 31(1):35-40. PubMed ID: 2856900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
